Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-18

Clinical Trial Update: ZYNRELEF for Pain Management in Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for ZYNRELEF assessing postoperative pain management after total knee arthroplasty; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

Sponsor: Baptist Health South Florida | Conditions: Post Operative Pain, Osteoarthritis, Knee | Phase 4 | Status: RECRUITING